Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumors
Conditions
Bones and Joints | Kidney | Soft Tissue | Pediatrics
Phase III
Volunteers
Health Professionals
What is the purpose of this trial?
The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumors.
- Trial withChildren's Oncology Group (COG)
- Start Date01/17/2019
- End Date02/01/2022
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
Sub-Investigators
- Last Updated12/22/2022
- Study HIC#2000023877